日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma

经典型或地方性卡波西肉瘤中的抑制性KIR2DL2受体和HHV-8

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-022-00798-0
Bortolotti, Daria; Corazza, Monica; Rotola, Antonella; Bencivelli, Dario; Schiuma, Giovanna; Danese, Elisabetta; Rizzo, Sabrina; Beltrami, Silvia; Rizzo, Roberta; Borghi, Alessandro
信号转导
发表日期：2023
文献求助 收藏

In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype

体外用8-甲氧基补骨脂素和紫外线A光处理单核细胞可诱导具有耐受表型的树突状细胞

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1111/j.1365-2249.2007.03372.x
Legitimo, A; Consolini, R; Failli, A; Fabiano, S; Bencivelli, W; Scatena, F; Mosca, F
树突状细胞
单核细胞
细胞生物学
树突状细胞
免疫/内分泌
发表日期：2007
文献求助 收藏

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score

欧洲硬皮病研究组制定系统性硬化症的疾病活动度标准。IV. 通过改良的罗德南皮肤评分评估皮肤增厚情况

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.62.9.904
Valentini, G; D'Angelo, S; Della Rossa, A; Bencivelli, W; Bombardieri, S
系统性硬化症
免疫/内分泌
发表日期：2003
文献求助 收藏

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

欧洲硬皮病研究组制定系统性硬化症的疾病活动度标准。III. 初步活动度标准的结构效度评估

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.62.9.901
Valentini, G; Bencivelli, W; Bombardieri, S; D'Angelo, S; Della Rossa, A; Silman, A J; Black, C M; Czirjak, L; Nielsen, H; Vlachoyiannopoulos, P G
系统性硬化症
免疫/内分泌
发表日期：2003
文献求助 收藏

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes

欧洲多中心研究：确定系统性硬化症的疾病活动度标准。II. 疾病活动度变量的识别和初步活动度指数的建立

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.60.6.592
Valentini, G; Della Rossa, A; Bombardieri, S; Bencivelli, W; Silman, A J; D'Angelo, S; Cerinic, M M; Belch, J F; Black, C M; Bruhlmann, P; Czirják, L; De Luca, A; Drosos, A A; Ferri, C; Gabrielli, A; Giacomelli, R; Hayem, G; Inanc, M; McHugh, N J; Nielsen, H; Rosada, M; Scorza, R; Stork, J; Sysa, A; van den Hoogen, F H; Vlachoyiannopoulos, P J
系统性硬化症
免疫/内分泌
发表日期：2001
文献求助 收藏

European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres

欧洲多中心研究：确定系统性硬化症的疾病活动度标准。I. 来自19个中心的290例患者的临床和流行病学特征

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.60.6.585
Della Rossa, A; Valentini, G; Bombardieri, S; Bencivelli, W; Silman, A J; D'Angelo, S; Cerinic, M M; Belch, J F; Black, C M; Becvar, R; Bruhlman, P; Cozzi, F; Czirják, L; Drosos, A A; Dziankowska, B; Ferri, C; Gabrielli, A; Giacomelli, R; Hayem, G; Inanc, M; McHugh, N J; Nielsen, H; Scorza, R; Tirri, E; van den Hoogen, F H; Vlachoyiannopoulos, P G
系统性硬化症
免疫/内分泌
发表日期：2001
文献求助 收藏